GSK’s new CEO Walmsley paid 25% less than predecessor WittyGlaxoSmithKline (GSK) has confirmed rumours that its incoming CEO Emma Walmsley will be paid less than her predecessor, Share XGSK’s new CEO Walmsley paid 25% less than predecessor Wittyhttps://pharmaphorum.com/news/gsks-new-ceo-walmsley-paid-25-less-predecessor-witty/
